Healius Pathology India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 3.18%
(FY 2022)
- Profit -37.65%
(FY 2022)
- Ebitda 2.79%
(FY 2022)
- Net Worth 12.00%
(FY 2022)
- Total Assets 11.70%
(FY 2022)
About Healius Pathology India
The Corporate was formerly known as Symbion Pathology (India) Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Yusuf Thasrawala and Stephen Humphries serve as directors at the Company.
- CIN/LLPIN
U72200KA2007FTC042522
- Company No.
042522
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
18 Apr 2007
- Date of AGM
18 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Healius Pathology India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yusuf Thasrawala  | Additional Director | 29-Feb-2024 | Current |
Stephen Humphries  | Additional Director | 10-May-2024 | Current |
Financial Performance and Corporate Structure Insights of Healius Pathology India.
Healius Pathology India Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.18% increase. The company also saw a substantial fall in profitability, with a 37.65% decrease in profit. The company's net worth Soared by an impressive increase of 12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healius Pathology India?
In 2020, Healius Pathology India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Healius Pathology India?
Healius Pathology India has a workforce of 690 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healius Pathology India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healius Pathology India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
